WHO decision challenges West to recognise Chinese Covid-19 vaccines

Published July 1, 2021
The WHO has already given the green light to the two Chinese jabs, made by Sinovac and Sinopharm. — AFP/File
The WHO has already given the green light to the two Chinese jabs, made by Sinovac and Sinopharm. — AFP/File

The World Health Organisation (WHO) said on Thursday that any Covid-19 vaccines it has authorised for emergency use should be recognised by countries as they open up their borders to inoculated travellers.

The move could challenge Western countries to broaden their acceptance of two apparently less effective Chinese vaccines, which the UN health agency has licensed but most European and North American countries have not.

In addition to vaccines by Pfizer-BioNTech, Moderna Inc, AstraZeneca and Johnson & Johnson, the WHO has also given the green light to the two Chinese jabs, made by Sinovac and Sinopharm.

In its aim to restore travel across Europe, the European Union (EU) said in May that it would only recognise people as vaccinated if they had received shots licensed by the European Medicines Agency — although it’s up to individual countries if they wish to let in travellers who have received other vaccines, including Russia’s Sputnik V. The EU drug regulator is currently considering licensing China’s Sinovac vaccine, but there is no timeline on a decision.

“Any measure that only allows people protected by a subset of WHO-approved vaccines to benefit from the reopening of travel ... would effectively create a two-tier system, further widening the global vaccine divide and exacerbating the inequities we have already seen in the distribution of Covid-19 vaccines,” a WHO statement said on Thursday. “It would negatively impact the growth of economies that are already suffering the most.”

The WHO said such moves are “undermining confidence in life-saving vaccines that have already been shown to be safe and effective”. In its reviews of the two Chinese vaccines, the UN health agency said both were found to significantly reduce the risk of hospitalisations and deaths.

The two Chinese shots are “inactivated” vaccines, made with killed coronavirus, whereas the Western-made shots are made with newer technologies that instead target the “spike” protein that coats the surface of the coronavirus.

Although Western countries have largely relied on vaccines made in the US and Europe, such as Pfizer-BioNTech and AstraZeneca, many developing countries including Pakistan have used the Chinese-made shots.

Earlier this year, the head of China’s Centre for Disease Control and Prevention acknowledged that the effectiveness of its home-grown shots was low. Numerous countries that have used millions of doses of the two Chinese shots, including the Seychelles and Bahrain, have seen Covid-19 surges even with relatively high levels of immunisation.

Opinion

Editorial

Kurram atrocity
Updated 22 Nov, 2024

Kurram atrocity

It would be a monumental mistake for the state to continue ignoring the violence in Kurram.
Persistent grip
22 Nov, 2024

Persistent grip

An audit of polio funds at federal and provincial levels is sorely needed, with obstacles hindering eradication efforts targeted.
Green transport
22 Nov, 2024

Green transport

THE government has taken a commendable step by announcing a New Energy Vehicle policy aiming to ensure that by 2030,...
Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...